Fieldview Capital Management »

United Therapeutics Corporation shares owned by Fieldview Capital Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Fieldview Capital Management from 13F filings

Historical chart of Fieldview Capital Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Fieldview Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Fieldview Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $400k 674 592.98

More positions owned by Fieldview Capital Management

First Ctzns Bancshares Inc D Cl A (FCNCA)
WesBan (WSBC)
Biogen Idec (BIIB)
Teradyne (TER)
Popular Com New (BPOP)
Broadstone Net Lease (BNL)
TowneBank (TOWN)
National Health Investors (NHI)
Darling International (DAR)
AutoZone (AZO)
Five Below (FIVE)
Atmus Filtration Technologies Ord (ATMU)
Hasbro (HAS)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Sun Communities (SUI)

View all positions for Fieldview Capital Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
Renaissance Technologies
State Street Corporation
Geode Capital Management
Henderson Group
AQR Capital Management
Citadel Advisors
Assetmark
Invesco
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation